Evidence map›Paper›PMID 29269866›Full record

SynthesisNature communications2017

DNA methylation signatures of illicit drug injection and hepatitis C are associated with HIV frailty.

Xinyu Zhang, Ying Hu, Amy C Justice, Boyang Li, Zuoheng Wang, Hongyu Zhao, John H Krystal, Ke Xu

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Association ofTranslational cancer research · 2026
    Article
  5. Article
  6. What Do We Know About Prevention of Frailty in Women?American journal of lifestyle medicine · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Epigenetic Age Acceleration Markers Are Associated With Physiologic Frailty and All-Cause Mortality in People With Human Immunodeficiency Virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xinyu ZhangDepartment of Psychiatry, Yale School of Medicine, 300 George Street, New Haven, CT, 06511, USA.ORCID http://orcid.org/0000-0001-8154-9334
Ying HuNational Cancer Institute Center for Biomedical Information & Information Technology, 9609 Medical Center Drive, Bethesda, MD, 20850, USA.
Amy C JusticeVA Connecticut Healthcare System, 950 Campbell Avenue, West Haven, CT, 06516, USA.ORCID http://orcid.org/0000-0003-0139-5502
Boyang LiDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, 06511, USA.
Zuoheng WangDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, 06511, USA.
Hongyu ZhaoDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, 06511, USA.
John H KrystalDepartment of Psychiatry, Yale School of Medicine, 300 George Street, New Haven, CT, 06511, USA.
Ke XuDepartment of Psychiatry, Yale School of Medicine, 300 George Street, New Haven, CT, 06511, USA. ke.xu@yale.edu.
Yale University · USNational Cancer Institute · USVA Connecticut Healthcare System · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
SUBSTANCE ABUSEK12DA000167 · NIDA · YALE UNIVERSITY · PI STEPHANIE S O'MALLEY, Marc N Potenza · 1991 to 2026
$17.7M
Enhancing Discovery of HIV Host Genetics using Drug Abuse and other InteractionsR01DA038632 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI JOHNSON, ERIC OTTO · 2014 to 2018
$3.7M
Novel Methods for Longitudinal Study of Gene-Environment Interplay in AlcoholismK01AA023321 · NIAAA · YALE UNIVERSITY · PI WANG, ZUOHENG · 2015 to 2019
$863k
Genome-wide DNA methylation in HIV infected drug usersR03DA039745 · NIDA · YALE UNIVERSITY · PI XU, KE · 2015 to 2016
$260k
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS K01 AA023321NIDA NIH HHS K12 DA000167NIDA NIH HHS R01 DA038632NIDA NIH HHS R03 DA039745
6 · The paper itself

Abstract

Intravenous illicit drug use (IDU) and hepatitis C infection (HCV) commonly co-occur among HIV-infected individuals. These co-occurring conditions may produce interacting epigenetic effects in white blood cells that influence immune function and health outcomes. Here, we report an epigenome-wide association analysis comparing IDU+/ HCV+ and IDU-/HCV- in 386 HIV-infected individuals as a discovery sample and in 412 individuals as a replication sample. We observe 6 significant CpGs in the promoters of 4 genes, NLRC5, TRIM69, CX3CR1, and BCL9, in the discovery sample and in meta-analysis. We identify 19 differentially methylated regions on chromosome 6 harboring MHC gene clusters. Importantly, a panel of IDU+/HCV+-associated CpGs discriminated HIV frailty based upon a validated index with an area under the curve of 79.3% for high frailty and 82.3% for low frailty. These findings suggest that IDU and HCV involve epigenetic programming and that their associated methylation signatures discriminate HIV pathophysiologic frailty.

Indexed as

DNA MethylationEpigenesis, GeneticAdultChromosomes, Human, Pair 5Cohort StudiesCpG IslandsFrailtyGenetic MarkersGenome-Wide Association StudyHepatitis CHIV InfectionsHumansMaleMiddle AgedPromoter Regions, GeneticReproducibility of ResultsGenetic Markers

Identifiers

PMID29269866
PMCPMC5740109
OpenAlexW2773162737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.